Ho Chi Minh, Vietnam – Jio Health, a provider of human-centered, technology-powered healthcare, has recently completed a US$20m Series B investment led by Singapore-based healthcare investor, Heritas Capital. Other investors in the round included Fuchsia Ventures, Kasikorn Bank Group, and existing investor, Monk’s Hills Ventures.
The fundraise represents the largest in the company’s history and will build on Jio Health’s aggressive growth, with plans to expand its Smart Clinics and omnichannel ecosystem across its primary market of Vietnam and pave the way for expansion into regional markets over the coming years.
“We’re excited to welcome a high-impact, high-conviction cohort of investors to join us on our mission to become the most consumer-centric healthcare company in Vietnam and across Southeast Asia. We plan to boldly invest into expanding our geographic footprint across Vietnam, enhancing our clinical and digital capabilities, and regionalizing the playbook for our ‘quality care, anytime, anywhere’ value proposition,” said Jio Health’s Founder & CEO Raghu Rai.
The Series B investment in Jio Health will extend its clinical service offering to more consumers and employers, support the launch of additional Smart Clinics in existing and new geographies, expand provider and clinical support teams, and further advance technology platform innovation.
Jio Health’s vertically integrated consumer healthcare value chain enables it to provide quality and affordable care wherever consumers shop, work, and live. The uniqueness of Jio Health’s model is that access to care is part of a larger omnichannel strategy that integrates prevention, multi-speciality care management, and ancillary diagnostic and pharmacy benefits to deliver better healthcare outcomes. Jio Health’s technology encompasses telemedicine, e-prescription fulfilment, digital medical records, and machine-learning for clinical decision support.
“Our team of 300+ care providers, engineers, and operators have each encountered the unpredictable impact of COVID at front-line hospitals, across their communities, and within their families. Their personal experiences have further validated the importance of our vision and deepened our commitment to transforming the access and delivery of care for millions of people across Southeast Asia. Our Series B funding will substantially accelerate our growth and scale the reach, impact, and affordability of our consumer healthcare ecosystem,” concludes Rai.